Head to Head Comparison: iRhythm Technologies (IRTC) vs. Its Rivals

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare iRhythm Technologies to related businesses based on the strength of its valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Risk and Volatility

iRhythm Technologies has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, iRhythm Technologies’ peers have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Profitability

This table compares iRhythm Technologies and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iRhythm Technologies -4.52% 26.88% 4.32%
iRhythm Technologies Competitors -303.57% -175.14% -22.20%

Earnings and Valuation

This table compares iRhythm Technologies and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
iRhythm Technologies $747.14 million -$44.55 million -77.85
iRhythm Technologies Competitors $1.87 billion $137.20 million 5.93

iRhythm Technologies’ peers have higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and target prices for iRhythm Technologies and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies 1 2 13 1 2.82
iRhythm Technologies Competitors 4295 10588 18372 832 2.46

iRhythm Technologies presently has a consensus price target of $164.07, indicating a potential upside of 80.14%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.64%. Given iRhythm Technologies’ stronger consensus rating and higher possible upside, equities research analysts clearly believe iRhythm Technologies is more favorable than its peers.

Summary

iRhythm Technologies beats its peers on 7 of the 13 factors compared.

About iRhythm Technologies

(Get Free Report)

iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.